Patent classifications
C07C311/00
N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
The invention relates to N-hydroxysulfonamide derivatives that donate nitroxyl (HNO) under physiological conditions and are useful in treating and/or preventing the onset and/or development of diseases or conditions that are responsive to nitroxyl therapy, including heart failure and ischemia/reperfusion injury. Novel N-hydroxysulfonamide derivatives release HNO at a controlled rate under physiological conditions, and the rate of HNO release is modulated by varying the nature and location of functional groups on the N-hydroxysulfonamide derivatives.
ULTRA SHORT ACTING ANTI-ARRHYTHMIC AGENTS
The present invention provides novel sotalol derivatives and pharmaceutical compositions containing the same that are are useful as pharmaceutical agents in the treatment of supraventricular and ventricular arrhythmias.
ULTRA SHORT ACTING ANTI-ARRHYTHMIC AGENTS
The present invention provides novel sotalol derivatives and pharmaceutical compositions containing the same that are are useful as pharmaceutical agents in the treatment of supraventricular and ventricular arrhythmias.
METHOD FOR PRODUCING BIS(FLUOROSULFONYL)IMIDE ALKALI METAL SALT
Provided is a method with which it is possible to conveniently produce bis(fluorosulfonyl)imide suitable as a nonaqueous electrolyte of a lithium ion secondary cell. The method for producing a bis(fluorosulfonyl)imide alkali metal salt of the invention is a production method for producing a bis(fluorosulfonyl)imide alkali metal salt by reacting bis(fluorosulfonyl)imide and an alkali metal halide in a reaction solution including an organic solvent, the method including a purification step for filtering out the bis(fluorosulfonyl)imide alkali metal from the solution after the reaction.
2,2′-diaminobiaryls having one primary and one secondary amine
Novel 2,2-diaminobiaryls having one primary and one secondary amine and an electrochemical process for preparation thereof.
N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
The invention relates to N-hydroxysulfonamide derivatives that donate nitroxyl (HNO) under physiological conditions and are useful in treating and/or preventing the onset and/or development of diseases or conditions that are responsive to nitroxyl therapy, including heart failure and ischemia/reperfusion injury. Novel N-hydroxysulfonamide derivatives release NHO at a controlled rate under physiological conditions, and the rate of HNO release is modulated by varying the nature and location of functional groups on the N-hydroxysulfonamide derivatives.
Surfactants and methods of making and using same
Anionic surfactants have a formula:
R.sub.fSO.sub.2N(H)CH.sub.2CH(CH.sub.3)OH; or
R.sub.fSO.sub.2N(H)(CH.sub.2CH.sub.2O).sub.xH, where x is an integer from 2-6. R.sub.f is a fluoroalkyl group having 3 to 8 carbon atoms. Neutral surfactants having a formula:
R.sub.fSO.sub.2N[CH.sub.2CH(CH.sub.3)OH].sub.2;(a)
R.sub.fSO.sub.2N[CH.sub.2CH(CH.sub.3)OH][(CH.sub.2CH.sub.2O).sub.nH], where n is an integer from 1-6;(b)
R.sub.fSO.sub.2N(R)[(CH.sub.2CH.sub.2O).sub.pH], where p is an integer from 2-6, and R is an alkyl group having 1 to 4 carbon atoms; or(c)
R.sub.fSO.sub.2N[(CH.sub.2CH.sub.2O).sub.qH][(CH.sub.2CH.sub.2O).sub.mH], where q is an integer from 1-6 and m is an integer from 3-6. R.sub.f is a fluoroalkyl group having 3 to 8 carbon atoms.(d)
Surfactants and methods of making and using same
Anionic surfactants have a formula:
R.sub.fSO.sub.2N(H)CH.sub.2CH(CH.sub.3)OH; or
R.sub.fSO.sub.2N(H)(CH.sub.2CH.sub.2O).sub.xH, where x is an integer from 2-6. R.sub.f is a fluoroalkyl group having 3 to 8 carbon atoms. Neutral surfactants having a formula:
R.sub.fSO.sub.2N[CH.sub.2CH(CH.sub.3)OH].sub.2;(a)
R.sub.fSO.sub.2N[CH.sub.2CH(CH.sub.3)OH][(CH.sub.2CH.sub.2O).sub.nH], where n is an integer from 1-6;(b)
R.sub.fSO.sub.2N(R)[(CH.sub.2CH.sub.2O).sub.pH], where p is an integer from 2-6, and R is an alkyl group having 1 to 4 carbon atoms; or(c)
R.sub.fSO.sub.2N[(CH.sub.2CH.sub.2O).sub.qH][(CH.sub.2CH.sub.2O).sub.mH], where q is an integer from 1-6 and m is an integer from 3-6. R.sub.f is a fluoroalkyl group having 3 to 8 carbon atoms.(d)
SURFACTANTS AND METHODS OF MAKING AND USING SAME
Anionic surfactants have a formula:
R.sub.fSO.sub.2N(H)CH.sub.2CH(CH.sub.3)OH; or
R.sub.fSO.sub.2N(H)(CH.sub.2CH.sub.2O).sub.xH, where x is an integer from 2-6. R.sub.f is a fluoroalkyl group having 3 to 8 carbon atoms. Neutral surfactants having a formula:
R.sub.fSO.sub.2N[CH.sub.2CH(CH.sub.3)OH].sub.2;(a)
R.sub.fSO.sub.2N[CH.sub.2CH(CH.sub.3)OH][(CH.sub.2CH.sub.2O).sub.nH], where n is an integer from 1-6;(b)
R.sub.fSO.sub.2N(R)[(CH.sub.2CH.sub.2O).sub.pH], where p is an integer from 2-6, and R is an alkyl group having 1 to 4 carbon atoms; or(c)
R.sub.fSO.sub.2N[(CH.sub.2CH.sub.2O).sub.qH][(CH.sub.2CH.sub.2O).sub.mH], where q is an integer from 1-6 and m is an integer from 3-6. R.sub.f is a fluoroalkyl group having 3 to 8 carbon atoms.(d)
Surfactants and methods of making and using same
Anionic surfactants have a formula: R.sub.fSO.sub.2N(H)CH.sub.2CH(CH.sub.3)OH; or R.sub.fSO.sub.2N(H)(CH.sub.2CH.sub.2O).sub.xH, where x is an integer from 2-6. R.sub.f is a fluoroalkyl group having 3 to 8 carbon atoms. Neutral surfactants having a formula: (a) R.sub.fSO.sub.2N[CH.sub.2CH(CH.sub.3)OH].sub.2; (b) R.sub.fSO.sub.2N[CH.sub.2CH(CH.sub.3)OH][(CH.sub.2CH.sub.2O).sub.nH], where n is an integer from 1-6; (c) R.sub.fSO.sub.2N(R)[(CH.sub.2CH.sub.2O).sub.pH], where p is an integer from 2-6, and R is an alkyl group having 1 to 4 carbon atoms; or (d) R.sub.fSO.sub.2N[(CH.sub.2CH.sub.2O).sub.qH][(CH.sub.2CH.sub.2O).sub.mH], where q is an integer from 1-6 and m is an integer from 3-6. R.sub.f is a fluoroalkyl group having 3 to 8 carbon atoms.